Netherlands· NL-daa2d9665efc
Naproxennatrium Sanias 275 mg, filmomhulde tabletten
A naproxen product containing naproxennatrium, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Naproxen is registered in 15 of 19 countries.
Countries holding a registration under ATC M01AE02 (naproxen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Naproxen · ATC M01AE02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of naproxen costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.16 in Italy to $0.82 in Switzerland — a ×4.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naproxen · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.82
- IT Italy$0.16
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NAPROXENNATRIUM
- Manufacturer
- Aurobindo Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- M01AE02
- ATC class
- Naproxen
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id116644
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
495 interactions on record for naproxen.
Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naproxen · interactions on record
495 records
- 58 severe
- 176 moderate
- 17 minor
- 161 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
83 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naproxen in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNALGESIN SKrka, d.d., Novo mesto, Novo mesto
- United StatesNaproxen sodiumDr. Reddy's Laboratories Inc.
- PolandAnapranAdamed Pharma S.A.
- BelgiumApranax 275 mgAtnahs Pharma Netherlands
- FranceAPRANAX 275 mg, comprimé pelliculéATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- United KingdomArthrosin 250 tabletsAshbourne Pharmaceuticals Ltd
- FinlandAleveBayer Oy
- CanadaALEVE BACK AND BODY PAINBAYER INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aleve, Miranax
- Belgium · Aleve, Apranax
- Bulgaria · Налгезин, Налгезин Форте
- Cyprus · Naprorex, Priaxen
- Czechia · Emoxen, Nalgesin
- Germany · Aspidolo, Dolormin Für Frauen Bei Menstruationsbeschwerden Mit
- Denmark · Bonyl, Naproxen Evolan
- Estonia · Emox, Nalgesin Forte
- Spain · Actromadol, Antalgin
- Finland · Miranax, Naprometin
- France · Aleve, Alevetabs
- United Kingdom (Northern Ireland) · Almus Period Pain Reliever, Boots Period Pain Reliever
- Greece · Anaprox, Naprosyn
- Croatia · Nalgesin, Nalgesin Forte
- Hungary · Aleve, Aleve Extra
- Ireland · Naprosyn Ec, Naproxen Azure Pharmaceuticals
- Iceland · Naproxen Viatris, Naproxen-E Viatris
- Italy · Dololibre, Femmedol
- Lithuania · Emox, Nalgesin Forte
- Luxembourg · Aleve, Apranax
- Latvia · Emox, Nalgedol
- Malta · Naprorex, Naprosyn
- Norway · Napren-E, Naproxen Evolan
- Poland · 4flex Puregel, Aleve
- Portugal · Actronadol, Ilgesin
- Romania · Mobilat Pro, Naldorex
- Sweden · Ipaflex, Naprocur
- Slovenia · Nalgesin, Nalgesin Forte
- Slovakia · Emoxen Gél, Nalgesin Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d320704f-4bda-4a07-8796-2d2139b0c384 GET /v1/drugs/d320704f-4bda-4a07-8796-2d2139b0c384?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116644_smpc.pdf",
"strength": null,
"atc_label": "Naproxen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116644",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"MACROGOL 8000",
"MAGNESIUMSTEARAAT (E 470b)",
"POVIDON K 30 (E 1201)",
"SILICIUMDIOXIDE, GEHYDRATEERD (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"NAPROXENNATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116644.pdf",
"authorised_at": "2016/03/16",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek$SEMICOLON$ Uitsluitend apotheek of drogist - UA meer dan 12 eenheden - UAD maximaal 12 eenheden",
"registration_number": "116644",
"additional_monitoring": "N"
}See everything about naproxen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.